These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 337158)

  • 1. Two mechanisms of migration inhibition factor induction by tumour antigens.
    Landolfo S; Herberman RB; Holden HT
    Nature; 1977 Nov; 270(5632):62-4. PubMed ID: 337158
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens.
    Ng AK; Ames RS; McIntire RK; Herberman RB
    Cancer Res; 1979 Dec; 39(12):4887-93. PubMed ID: 387218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular immunity to murine sarcoma virus-induced tumors as measured by macrophage migration inhibition assays.
    Landolfo S; Herberman RB; Holden HT
    J Natl Cancer Inst; 1977 Dec; 59(6):1675-83. PubMed ID: 200758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blocking of syngeneic effector T cells by soluble tumour antigens.
    Plata F; Levy JP
    Nature; 1974 May; 249(454):271-4. PubMed ID: 4545403
    [No Abstract]   [Full Text] [Related]  

  • 5. Blocking effect of serum from tumor-bearing animals on macrophage migration inhibition with tumor antigens.
    Halliday WJ
    J Immunol; 1971 Mar; 106(3):855-7. PubMed ID: 5547301
    [No Abstract]   [Full Text] [Related]  

  • 6. Macrophage-lymphocyte interaction in migration inhibition factor (MIF) production against soluble or cellular tumor-associated antigens. I. Characteristics and genetic control of two different mechanisms of stimulating MIF production.
    Landolfo S; Herberman RB; Holden HT
    J Immunol; 1978 Aug; 121(2):695-701. PubMed ID: 79613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Induction of T-cell producers of the macrophage migration inhibitory factor by the products of the K-, I- and D-regions of the H-2 complex in mice].
    Kharkevich DD; Suslov AP
    Biull Eksp Biol Med; 1985 Apr; 99(4):484-6. PubMed ID: 3886043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further evidence for the involvement of thymus-processed lymphocytes in syngeneic tumor cell cytolysis.
    Plata F; Gomard E; Leclerc JC; Levy JP
    J Immunol; 1973 Sep; 111(3):667-71. PubMed ID: 4542607
    [No Abstract]   [Full Text] [Related]  

  • 9. Suppression of cell-mediated tumour immunity by Corynebacterium parvum.
    Kirchner H; Glaser M; Herberman R
    Nature; 1975 Oct; 257(5525):396-8. PubMed ID: 170531
    [No Abstract]   [Full Text] [Related]  

  • 10. Secondary in vitro generation of cytolytic T-lymphocytes (CTL's) in the murine sarcoma virus system. Virus-specific CTL induction across the H-2 barrier.
    Collavo D; Parenti A; Biasi G; Chieco-Bianchi L; Colombatti A
    J Natl Cancer Inst; 1978 Sep; 61(3):885-90. PubMed ID: 80457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukocyte adherence inhibition response to murine sarcoma virus-induced tumors. II. Requirement for T-cell subpopulations and macrophages.
    Sarlo KT; Mortensen RF
    Cell Immunol; 1983 Jul; 79(2):211-9. PubMed ID: 6307531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different cellular site for the production of murine macrophage migration inhibitory factor and immune interferon (Type II).
    Neumann C; Sorg C
    Adv Exp Med Biol; 1979; 114():479-83. PubMed ID: 380299
    [No Abstract]   [Full Text] [Related]  

  • 13. Stimulation of mouse migration inhibitory factor (MIF) production form MSV-immune lymphocytes by soluble tumor-associated antigen: requirement for histocompatible macrophages.
    Landolfo S; Herberman RB; Holden HT
    J Immunol; 1977 Apr; 118(4):1244-8. PubMed ID: 191532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell-dependent reactivity against tumor-associated antigens on allogeneic target cells.
    Holden HT; Landolfo S; Herberman RB
    Transplant Proc; 1977 Mar; 9(1):1149-52. PubMed ID: 194368
    [No Abstract]   [Full Text] [Related]  

  • 15. [Kinetics of production of macrophage migration inhibitory factors in mixed culture of lymphocytes and tumor cells].
    Kharkevich DD; Suslov AP
    Biull Eksp Biol Med; 1982 Feb; 93(2):53-5. PubMed ID: 6461371
    [No Abstract]   [Full Text] [Related]  

  • 16. Macrophage migration inhibition with mouse tumor antigens: properties of serum and peritoneal cells during tumor growth and after tumor loss.
    Halliday WJ
    Cell Immunol; 1972 Jan; 3(1):113-22. PubMed ID: 5061636
    [No Abstract]   [Full Text] [Related]  

  • 17. Stimulation of tumor cell growth in vitro: a critical evaluation of immunologic specificity.
    Lamon EW
    J Natl Cancer Inst; 1977 Sep; 59(3):769-74. PubMed ID: 70536
    [No Abstract]   [Full Text] [Related]  

  • 18. Specific MIF release by rat lymphocytes following incubation with syngeneic anti-tumor "immune" RNA.
    Waldman SR; Pilch YH
    Cell Immunol; 1975 Jul; 18(1):246-50. PubMed ID: 1095213
    [No Abstract]   [Full Text] [Related]  

  • 19. Detection of cellular immunity to murine sarcoma virus-induced tumors by leukocyte adherence inhibition.
    Mortensen RF
    J Natl Cancer Inst; 1979 Jan; 62(1):157-63. PubMed ID: 214608
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunity to murine sarcoma virus-inducted tumors. I. Specific T lymphocytes active in macrophage migration inhibition and lymphocyte transformation.
    Gorczynski RM
    J Immunol; 1974 May; 112(5):1815-25. PubMed ID: 4361977
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.